Chai Discovery raises $400M Series C at a $3.8B valuation for AI molecular design

Chai Discovery raised $400 million at a $3.8 billion valuation, tripling its worth in seven months, in a round led by Index Ventures with OpenAI among the backers. Its generative models design antibodies and molecules from scratch for partners including Eli Lilly and Pfizer.